
Publications
Innovations in Oral Therapies for Inflammatory Bowel Disease
Citation
Ma C, Battat R, Dulai PS, Parker CE, Sandborn WJ, Feagan BG, Jairath V. Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs. 2019 Aug;79(12):1321-1335. doi: 10.1007/s40265-019-01169-y. PMID: 31317509.
Abstract
Prior to the biologic era, the medical management of patients with inflammatory bowel disease (IBD) was dominated by the use of aminosalicylates, corticosteroids, and immunosuppressants.
Tags
Receptors Lysosphingolipid, Janus kinase inhibitors, Heterocyclic Compounds 3-Ring, Piperidines, Pyrimidines, Pyrroles, Inflammatory Bowel Disease, Triazoles, IBD, Indans, Drug Therapy, Oxadiazoles, therapeutic use, Anti-Inflammatory Agents Non-Steroidal, Adverse Effects, Phosphodiesterase Inhibitors, Mesalamine
Read More